Search results
How sham patents are hurting the pharma industry
Pharmaceutical Technology via Yahoo Finance· 13 hours ago“[The Orange Book] is a very unusual system that has greatly encouraged generic companies to challenge patents,” Singla continues. Singla specialises in...
'Total fear:' Local families describe struggle to find needed medications as shortages hit peak
Dayton Daily News, Ohio via Yahoo News· 1 hour agoMay 7—The number of drugs in shortage reached a record high this year and has pushed some local families to spend hours calling multiple pharmacies to try to find the medication, or even ration ...
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Zacks via Yahoo Finance· 1 day agoThe earnings season for the drug/biotech sector is now in its final lap, with two S&P 500 companies,...
New Jersey drug company to provide cash, naloxone to Delaware in latest opioid settlement
Delaware Online | The News Journal via Yahoo News· 24 hours agoNew Jersey-based drug manufacturer Amneal Pharmaceuticals has become the latest company to reach a settlement agreement with Delaware and other states for ...
Cost and Piqray: Financial assistance options, savings, more
Medical News Today· 1 day agoThe cost of the drug, with and without insurance, can depend on several factors, such as whether...
Earnings call: Assertio Holdings reports growth and CEO search progress By Investing.com
Investing.com· 10 hours agoThe company highlighted a significant 32% quarter-over-quarter growth in Rolvedon sales and the...
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
Zacks via Yahoo Finance· 9 hours agoThis, in turn, prompts collaboration deals with either pharma or biotech bigwigs, wherein sales are...
Indian drugmaker Lupin misses quarterly profit estimates as costs rise
Reuters via Yahoo Finance· 1 day agoIn March, Lupin decided to carve out its trade generics business in India into a separate unit, Lupin Life Sciences...average estimate of 5.16 billion rupees, according to ...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
WJTV Jackson· 7 days agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the...
India's Dr Reddy's expects healthy products pipeline in North America for FY25
Reuters· 6 hours ago, opens new tab expects a healthy products pipeline in its key North American market in the fiscal year 2024-25, the generic drugmaker said on Tuesday, after it reported a ...
